Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.7901
+0.0401 (5.35%)
At close: Apr 2, 2025, 4:00 PM
0.7770
-0.0131 (-1.66%)
After-hours: Apr 2, 2025, 6:56 PM EDT

Cue Biopharma Statistics

Total Valuation

Cue Biopharma has a market cap or net worth of $50.05 million. The enterprise value is $39.34 million.

Market Cap 50.05M
Enterprise Value 39.34M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

Cue Biopharma has 63.35 million shares outstanding. The number of shares has increased by 23.11% in one year.

Current Share Class 63.35M
Shares Outstanding 63.35M
Shares Change (YoY) +23.11%
Shares Change (QoQ) +44.91%
Owned by Insiders (%) 0.55%
Owned by Institutions (%) 20.31%
Float 63.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.55
Forward PS 8.09
PB Ratio 2.65
P/TBV Ratio 3.08
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.24
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.51.

Current Ratio 1.84
Quick Ratio 1.78
Debt / Equity 0.51
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -52.25

Financial Efficiency

Return on equity (ROE) is -149.03% and return on invested capital (ROIC) is -66.52%.

Return on Equity (ROE) -149.03%
Return on Assets (ROA) -55.47%
Return on Invested Capital (ROIC) -66.52%
Return on Capital Employed (ROCE) -224.80%
Revenue Per Employee $175,226
Profits Per Employee -$767,434
Employee Count 53
Asset Turnover 0.20
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -58.42% in the last 52 weeks. The beta is 2.03, so Cue Biopharma's price volatility has been higher than the market average.

Beta (5Y) 2.03
52-Week Price Change -58.42%
50-Day Moving Average 1.19
200-Day Moving Average 1.08
Relative Strength Index (RSI) 28.84
Average Volume (20 Days) 146,356

Short Selling Information

The latest short interest is 859,887, so 1.36% of the outstanding shares have been sold short.

Short Interest 859,887
Short Previous Month 955,190
Short % of Shares Out 1.36%
Short % of Float 1.36%
Short Ratio (days to cover) 4.75

Income Statement

In the last 12 months, Cue Biopharma had revenue of $9.29 million and -$40.67 million in losses. Loss per share was -$0.72.

Revenue 9.29M
Gross Profit 9.29M
Operating Income -41.59M
Pretax Income -49.97M
Net Income -40.67M
EBITDA -41.20M
EBIT -41.59M
Loss Per Share -$0.72
Full Income Statement

Balance Sheet

The company has $23.39 million in cash and $8.88 million in debt, giving a net cash position of $14.51 million or $0.23 per share.

Cash & Cash Equivalents 23.39M
Total Debt 8.88M
Net Cash 14.51M
Net Cash Per Share $0.23
Equity (Book Value) 17.50M
Book Value Per Share 0.28
Working Capital 11.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.33 million and capital expenditures -$66,000, giving a free cash flow of -$36.40 million.

Operating Cash Flow -36.33M
Capital Expenditures -66,000
Free Cash Flow -36.40M
FCF Per Share -$0.57
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -447.86%
Pretax Margin -437.97%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Cue Biopharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -23.11%
Shareholder Yield -23.11%
Earnings Yield -75.54%
FCF Yield -67.59%

Analyst Forecast

The average price target for Cue Biopharma is $4.75, which is 501.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.75
Price Target Difference 501.19%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 16.03%
EPS Growth Forecast (5Y) -7.28%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1